Uppsala Reports editor
Spontaneous adverse drug reaction reports have been the proverbial ‘bread and butter’ for signal detection since the beginnings of pharmacovigilance. But times are changing, and with the abundance of data now available in a society that has gone digital, it is time to explore new data sources to detect signals.
Join Federica Santoro and Daniele Sartori, a pharmacovigilance scientist at UMC and doctoral researcher at the University of Oxford, discuss expanding sources of evidence for more reliable signal detection.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here: